Your session is about to expire
← Back to Search
Tough Talks COVID for Increasing COVID-19 Vaccine Uptake among African American Young Adults in the South
This trial will test a new intervention to increase vaccine uptake among 360 Black young adults from Alabama, Georgia, and North Carolina. The intervention will be compared to the standard of care, and the primary outcome will be vaccine uptake.
- Vaccine Uptake
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You own a smartphone.You self-identify as an African American/Black person.
- Group 1: Standard of Care (Control)
- Group 2: TT-C Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the criteria for joining this clinical research endeavor?
"Patients between 18 and 29 years old, with a confirmed Covid 19 diagnosis, can apply to this clinical trial. Currently, up to 360 individuals are being accepted into the study's cohort."
Are there any existing opportunities for individuals to join this clinical experiment?
"Unfortunately, the clinicaltrials.gov registry shows that this specific trial is not currently enlisting patients after its most recent update on November 4th 2022. However, there are 1038 other medical studies actively recruiting participants at present."
Is it feasible for seniors to partake in this medical trial?
"Eligible participants for this study consist of those over 18 years old and under 29."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends